Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomePension (IS)Profit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eastman Chemical (EMN) EBITDA (2016 - 2025)

Eastman Chemical (EMN) has disclosed EBITDA for 17 consecutive years, with $277.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA fell 5.14% year-over-year to $277.0 million, compared with a TTM value of $629.0 million through Dec 2025, down 30.88%, and an annual FY2025 reading of $629.0 million, down 30.88% over the prior year.
  • EBITDA was $277.0 million for Q4 2025 at Eastman Chemical, up from $68.0 million in the prior quarter.
  • Across five years, EBITDA topped out at $399.0 million in Q3 2021 and bottomed at -$129.0 million in Q2 2021.
  • Average EBITDA over 5 years is $201.6 million, with a median of $239.0 million recorded in 2023.
  • Peak annual rise in EBITDA hit 9225.0% in 2021, while the deepest fall reached 960.0% in 2021.
  • Year by year, EBITDA stood at $373.0 million in 2021, then tumbled by 113.14% to -$49.0 million in 2022, then soared by 679.59% to $284.0 million in 2023, then rose by 2.82% to $292.0 million in 2024, then fell by 5.14% to $277.0 million in 2025.
  • Business Quant data shows EBITDA for EMN at $277.0 million in Q4 2025, $68.0 million in Q3 2025, and $108.0 million in Q2 2025.